Evidence map›Paper›PMID 17927981›Full record

ArticleExperimental neurology2007

SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Andrea M Vincent, James W Russell, Kelli A Sullivan, Carey Backus, John M Hayes, Lisa L McLean, Eva L Feldman

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  18. RAGE Differentially AlteredFrontiers in physiology · 2021
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrea M VincentDepartment of Neurology, University of Michigan, 5017 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-0588, USA.
James W Russell
Kelli A Sullivan
Carey Backus
John M Hayes
Lisa L McLean
Eva L Feldman
University of Michigan–Ann Arbor · USUniversity of Maryland, College Park · US

Funding

PUBLIC HEALTH DEMONSTRATIONP60DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MYERS, MARTIN G · 1985 to 2012
$26.5M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Mouse Models of Diabetic Nephropathy and NeuropathyU01DK060994 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROSIUS, FRANK C · 2001 to 2005
$3.3M
GLUCOTOXICITY MEDIATES APOPTOSIS IN DIABETIC NEUROPATHYR01NS038849 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FELDMAN, EVA LUCILLE · 1998 to 2005
$854k
IGFS MEDIATE MOTILITY IN HUMAN NEUROBLASTOMA CELLSR01NS036778 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FELDMAN, EVA L · 1998 to 2002
$636k
Oxidative Stress Induces Apoptosis in Diabetic NeuronsK02NS042056 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUSSELL, JAMES W · 2002 to 2006
$496k
NIDDK NIH HHS DK20572NIDDK NIH HHS DK60994NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK092926NIDDK NIH HHS P60 DK020572NIDDK NIH HHS U01 DK060994NINDS NIH HHS K02 NS042056NINDS NIH HHS NS36778NINDS NIH HHS NS38849NINDS NIH HHS NS42056NINDS NIH HHS R01 NS036778NINDS NIH HHS R01 NS038849
6 · The paper itself

Abstract

Hyperglycemia-induced oxidative stress is an inciting event in the development of diabetic complications including diabetic neuropathy. Our observations of significant oxidative stress and morphological abnormalities in mitochondria led us to examine manganese superoxide dismutase (SOD2), the enzyme responsible for mitochondrial detoxification of oxygen radicals. We demonstrate that overexpression of SOD2 decreases superoxide (O(2)(-)) in cultured primary dorsal root ganglion (DRG) neurons and subsequently blocks caspase-3 activation and cellular injury. Underexpression of SOD2 in dissociated DRG cultures from adult SOD2(+/-) mice results in increased levels of O2-, activation of caspase-3 cleavage and decreased neurite outgrowth under basal conditions that are exacerbated by hyperglycemia. These profound changes in sensory neurons led us to explore the effects of decreased SOD2 on the development of diabetic neuropathy (DN) in mice. DN was assessed in SOD2(+/-) C57BL/6J mice and their SOD2(+/+) littermates following streptozotocin (STZ) treatment. These animals, while hyperglycemic, do not display any signs of DN. DN was observed in the C57BL/6Jdb/db mouse, and decreased expression of SOD2 in these animals increased DN. Our data suggest that SOD2 activity is an important cellular modifier of neuronal oxidative defense against hyperglycemic injury.

Indexed as

AnimalsCaspase 3Cells, CulturedDiabetes MellitusDiabetes Mellitus, ExperimentalDiabetic NeuropathiesEnzyme ActivationGanglia, SpinalMembrane PotentialsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMitochondrial MembranesNeural ConductionNeurons, AfferentCaspase 3Neuroprotective AgentsSuperoxide DismutaseSuperoxide Dismutase 2

Identifiers

PMID17927981
PMCPMC2190625
OpenAlexW2052899912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.